Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Alterna Therapeutics Inc
Profile last edited on: 5/15/20      CAGE: 7JRY4      UEI: Q5T4RMK2C677

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2015
First Award
2019
Latest Award
2019
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

701 West Main Street Suite 200
Durham, NC 27701
   (919) 473-9296
   N/A
   www.alternatherapeutics.com/
Location: Single
Congr. District: 01
County: Durham

Public Profile

In September 2018 - perhaps coincident with announcement of the firm's first NIH Phase I award - Pitchbook indicated the firm as out of business: Website is non-operational. Structured around therapeutics addressing treatment of diabetes and obesity, Alterna Therapeutics had been targeting fat tissues known to limit inflammation and SHIP enzyme for the treatment of obesity, enabling patients to control obesity without any side effects

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$225,000
Phase II Dollars
$0
Total Awarded
$225,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2019 1 NIH $225,000
Project Title: Novel and Potent SHIP1 Inhibitors for Improving Hematologic Recovery Following Myelosuppressive Therapies

Key People / Management

  William Garrow Kerr

  Christopher Meldrum

Company News

There are no news available.